Cargando…
Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133254/ https://www.ncbi.nlm.nih.gov/pubmed/2793873 http://dx.doi.org/10.1016/0092-1157(89)90013-9 |
_version_ | 1783517591711514624 |
---|---|
author | Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy |
author_facet | Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy |
author_sort | Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7133254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1989 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71332542020-04-08 Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy J Biol Stand Article Published by Elsevier Ltd. 1989 2004-04-15 /pmc/articles/PMC7133254/ /pubmed/2793873 http://dx.doi.org/10.1016/0092-1157(89)90013-9 Text en Copyright © 1989 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man |
title | Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man |
title_full | Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man |
title_fullStr | Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man |
title_full_unstemmed | Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man |
title_short | Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man |
title_sort | notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133254/ https://www.ncbi.nlm.nih.gov/pubmed/2793873 http://dx.doi.org/10.1016/0092-1157(89)90013-9 |
work_keys_str_mv | AT committeeforproprietarymedicinalproductsadhocworkingpartyonbiotechnologypharmacy notestoapplicantsformarketingauthorizationsontheproductionandqualitycontrolofmonoclonalantibodiesofmurineoriginintendedforuseinman |